VERICEL CORP (VCEL) — insider trading
Health Care · NASDAQ
VERICEL CORP (VCEL) has 76 reported SEC Form 4 insider transactions in our data, including 22 open-market sales among the most recent 76 (latest 2026-08-12).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | MCLAUGHLIN KEVIN F | Director | Option exercise / conversion (derivative) | 7,000 | — | $0 | Form 4 |
| 2026-08-12 | MCLAUGHLIN KEVIN F | Director | Open-market sale | 7,000 | $44.53 | $311.7K | Form 4 |
| 2026-08-12 | MCLAUGHLIN KEVIN F | Director | Option exercise / conversion | 7,000 | $13.05 | $91.3K | Form 4 |
| 2026-08-03 | Halpin Michael | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 10,000 | — | $0 | Form 4 |
| 2026-08-03 | Halpin Michael | Officer (Chief Operating Officer) | Open-market sale | 10,000 | $46.84 | $468.4K | Form 4 |
| 2026-08-03 | Halpin Michael | Officer (Chief Operating Officer) | Option exercise / conversion | 10,000 | $16.66 | $166.6K | Form 4 |
| 2026-07-30 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 500 | — | $0 | Form 4 |
| 2026-07-30 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 2,500 | — | $0 | Form 4 |
| 2026-07-30 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 1,500 | — | $0 | Form 4 |
| 2026-07-30 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Open-market sale | 500 | $48.90 | $24.4K | Form 4 |
| 2026-07-30 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Option exercise / conversion | 500 | $29.82 | $14.9K | Form 4 |
| 2026-07-30 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Open-market sale | 2,500 | $48.90 | $122.3K | Form 4 |
| 2026-07-30 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Option exercise / conversion | 2,500 | $29.82 | $74.5K | Form 4 |
| 2026-07-30 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Open-market sale | 1,500 | $48.90 | $73.3K | Form 4 |
| 2026-07-30 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Option exercise / conversion | 1,500 | $34.90 | $52.4K | Form 4 |
| 2026-06-26 | Flynn Sean C. | Officer (Chief Legal Officer) | Option exercise / conversion (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-06-26 | Flynn Sean C. | Officer (Chief Legal Officer) | Open-market sale | 15,000 | $45.64 | $684.6K | Form 4 |
| 2026-06-26 | Flynn Sean C. | Officer (Chief Legal Officer) | Option exercise / conversion | 15,000 | $16.25 | $243.8K | Form 4 |
| 2026-06-26 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 5,000 | — | $0 | Form 4 |
| 2026-06-26 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 5,000 | — | $0 | Form 4 |
| 2026-06-26 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Open-market sale | 5,000 | $45.00 | $225.0K | Form 4 |
| 2026-06-26 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Option exercise / conversion | 5,000 | $29.82 | $149.1K | Form 4 |
| 2026-06-26 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Open-market sale | 5,000 | $45.00 | $225.0K | Form 4 |
| 2026-06-26 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Option exercise / conversion | 5,000 | $29.82 | $149.1K | Form 4 |
| 2026-06-26 | Mara Joseph Anthony Jr | Officer (Chief Financial Officer) | Open-market sale | 5,000 | $44.75 | $223.8K | Form 4 |
| 2026-06-26 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 2,500 | — | $0 | Form 4 |
| 2026-06-26 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Open-market sale | 2,500 | $44.90 | $112.3K | Form 4 |
| 2026-06-26 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Option exercise / conversion | 2,500 | $29.82 | $74.5K | Form 4 |
| 2026-06-26 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Open-market sale | 232 | $44.90 | $10.4K | Form 4 |
| 2026-06-18 | Flynn Sean C. | Officer (Chief Legal Officer) | Option exercise / conversion (derivative) | 15,000 | — | $0 | Form 4 |
| 2026-06-18 | Flynn Sean C. | Officer (Chief Legal Officer) | Open-market sale | 15,000 | $40.21 | $603.1K | Form 4 |
| 2026-06-18 | Flynn Sean C. | Officer (Chief Legal Officer) | Option exercise / conversion | 15,000 | $16.25 | $243.8K | Form 4 |
| 2026-06-18 | Halpin Michael | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 10,000 | — | $0 | Form 4 |
| 2026-06-18 | Halpin Michael | Officer (Chief Operating Officer) | Open-market sale | 10,000 | $40.24 | $402.4K | Form 4 |
| 2026-06-18 | Halpin Michael | Officer (Chief Operating Officer) | Option exercise / conversion | 10,000 | $16.66 | $166.6K | Form 4 |
| 2026-06-02 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 4,375 | — | $0 | Form 4 |
| 2026-06-02 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Open-market sale | 4,375 | $35.00 | $153.1K | Form 4 |
| 2026-06-02 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Option exercise / conversion | 4,375 | $16.66 | $72.9K | Form 4 |
| 2026-05-13 | MCLAUGHLIN KEVIN F | Director | Option exercise / conversion (derivative) | 3,500 | — | $0 | Form 4 |
| 2026-05-13 | MCLAUGHLIN KEVIN F | Director | Option exercise / conversion (derivative) | 3,500 | — | $0 | Form 4 |
| 2026-05-13 | MCLAUGHLIN KEVIN F | Director | Open-market sale | 3,500 | $32.82 | $114.9K | Form 4 |
| 2026-05-13 | MCLAUGHLIN KEVIN F | Director | Option exercise / conversion | 3,500 | $13.05 | $45.7K | Form 4 |
| 2026-05-13 | MCLAUGHLIN KEVIN F | Director | Open-market sale | 3,500 | $32.83 | $114.9K | Form 4 |
| 2026-05-13 | MCLAUGHLIN KEVIN F | Director | Option exercise / conversion | 3,500 | $2.63 | $9.2K | Form 4 |
| 2026-05-11 | Wotton Paul K | Director | Open-market sale | 7,500 | $32.64 | $244.8K | Form 4 |
| 2026-05-11 | Wotton Paul K | Director | Open-market sale | 2,500 | $33.05 | $82.6K | Form 4 |
| 2026-05-07 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Open-market sale | 1,422 | $40.50 | $57.6K | Form 4 |
| 2026-05-07 | Mara Joseph Anthony Jr | Officer (Chief Financial Officer) | Open-market sale | 5,000 | $40.50 | $202.5K | Form 4 |
| 2026-05-06 | SIEGAL JONATHAN | Officer (Principal Accounting Officer) | Open-market sale | 3,433 | $38.00 | $130.5K | Form 4 |
| 2026-04-29 | ZERBE ROBERT L MD | Director | Grant / award / vesting (derivative) | 3,200 | — | $0 | Form 4 |
| 2026-04-29 | ZERBE ROBERT L MD | Director | Grant / award / vesting (derivative) | 8,000 | — | $0 | Form 4 |
| 2026-04-29 | ZERBE ROBERT L MD | Director | Option exercise / conversion (derivative) | 3,200 | — | $0 | Form 4 |
| 2026-04-29 | ZERBE ROBERT L MD | Director | Option exercise / conversion | 3,200 | — | — | Form 4 |
| 2026-04-29 | WRIGHT LISA | Director | Grant / award / vesting (derivative) | 3,200 | — | $0 | Form 4 |
| 2026-04-29 | WRIGHT LISA | Director | Grant / award / vesting (derivative) | 8,000 | — | $0 | Form 4 |
| 2026-04-29 | WRIGHT LISA | Director | Option exercise / conversion (derivative) | 3,200 | — | — | Form 4 |
| 2026-04-29 | WRIGHT LISA | Director | Option exercise / conversion | 3,200 | — | — | Form 4 |
| 2026-04-29 | Wotton Paul K | Director | Grant / award / vesting (derivative) | 3,200 | — | $0 | Form 4 |
| 2026-04-29 | Wotton Paul K | Director | Grant / award / vesting (derivative) | 8,000 | — | $0 | Form 4 |
| 2026-04-29 | Wotton Paul K | Director | Option exercise / conversion (derivative) | 3,200 | — | — | Form 4 |
| 2026-04-29 | Wotton Paul K | Director | Option exercise / conversion | 3,200 | — | — | Form 4 |
| 2026-04-29 | Rubino Alan L | Director | Grant / award / vesting (derivative) | 3,200 | — | $0 | Form 4 |
| 2026-04-29 | Rubino Alan L | Director | Grant / award / vesting (derivative) | 8,000 | — | $0 | Form 4 |
| 2026-04-29 | Rubino Alan L | Director | Option exercise / conversion (derivative) | 3,200 | — | $0 | Form 4 |
| 2026-04-29 | Rubino Alan L | Director | Option exercise / conversion | 3,200 | — | — | Form 4 |
| 2026-04-29 | Hagen Heidi | Director | Grant / award / vesting (derivative) | 3,200 | — | $0 | Form 4 |
| 2026-04-29 | Hagen Heidi | Director | Grant / award / vesting (derivative) | 8,000 | — | $0 | Form 4 |
| 2026-04-29 | Hagen Heidi | Director | Option exercise / conversion (derivative) | 3,200 | — | $0 | Form 4 |
| 2026-04-29 | Hagen Heidi | Director | Option exercise / conversion | 3,200 | — | — | Form 4 |
| 2026-04-29 | MCLAUGHLIN KEVIN F | Director | Grant / award / vesting (derivative) | 3,200 | — | $0 | Form 4 |
| 2026-04-29 | MCLAUGHLIN KEVIN F | Director | Grant / award / vesting (derivative) | 8,000 | — | $0 | Form 4 |
| 2026-04-29 | MCLAUGHLIN KEVIN F | Director | Option exercise / conversion (derivative) | 3,200 | — | $0 | Form 4 |
| 2026-04-29 | MCLAUGHLIN KEVIN F | Director | Option exercise / conversion | 3,200 | — | — | Form 4 |
| 2026-04-02 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 3,472 | — | $0 | Form 4 |
| 2026-04-02 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Open-market sale | 3,472 | $35.00 | $121.5K | Form 4 |
| 2026-04-02 | Hopper Jonathan Mark | Officer (Chief Medical Officer) | Option exercise / conversion | 3,472 | $10.95 | $38.0K | Form 4 |
Ask the chat about VCEL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: VERICEL CORP (VCEL).
Last updated 2026-08-12 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.